Sufang Qiu

机构：Fujian Medical University, Fujian Provincial Cancer Hospital · ORCID：0000-0001-7660-6955

发表论文 144 篇 · 总被引 2696 次 · h-index 28

代表论文

• SPP1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma (2024 · International Immunopharmacology · 被引 28)
• Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China (2025 · The Lancet · 被引 18)
• Plasma Epstein-Barr Virus DNA Temporal Clearance Pattern During Induction-Concurrent (Chemo)Radiation Therapy for Risk Stratification in Nasopharyngeal Carcinoma (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 9)
• Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas (2025 · BMC Oral Health · 被引 6)
• Becotatug vedotin vs. chemotherapy in pre-heavily treated advanced nasopharyngeal carcinoma: A randomized, controlled, multicenter, open-label study. (2025 · Journal of Clinical Oncology · 被引 6)
• Noninvasive nasopharyngeal cancer screening via salivary DNA detection using label-free surface-enhanced Raman spectroscopy (2025 · Talanta · 被引 3)